Erlotinib is a kind of EGFR inhibitor. It’s used to treat NSCLC and pancreatic cancer in people who have EGFR mutations. It works by stopping EGFR signaling.
There are three doses to choose from: 25mg, 100mg, and 150mg, and they all come as coated tablets. The dose doctors usually recommend is 150mg, and you should take it on an empty stomach once every day. These tablets come in bottles with 30 in each.
